Purchases and Sales Made in Q1 2024 in Xilio Therapeutics, Inc. (XLO)
This table provides information about the institutional ownership of Xilio Therapeutics, Inc. (XLO) during Q1 2024. The information is specifically focused on institutions that hold shares of Xilio Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 13, 2024
Q1 2024
|
Balyasny Asset Management LLC
Chicago, IL |
BUY
|
- |
339KNew |
$186K - $366K
|
339K
$298K
|
|
|
Aug 16, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
BUY
|
- |
94.6K+ 74.36% |
$52.1K - $102K
|
222K
$195K
|
|
|
May 15, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
BUY
|
- |
94.6K+ 74.36% |
$52.1K - $102K
|
222K
$195K
|
|
|
May 15, 2024
Q1 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
BUY
|
- |
39.8K+ 131.29% |
$21.9K - $43K
|
70.2K
$61.8K
|
|
|
May 13, 2024
Q1 2024
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
39.7K+ 18.95% |
$21.9K - $42.9K
|
249K
$220K
|
|
|
May 10, 2024
Q1 2024
|
Seven Bridge Financial Group, LLC
|
BUY
|
- |
31KNew |
$17.1K - $33.5K
|
31K
$27.3K
|
|
|
Apr 22, 2024
Q1 2024
|
Pfg Investments, LLC
Woodbury, NY |
BUY
|
- |
30KNew |
$16.5K - $32.4K
|
30K
$26.4K
|
|
|
May 15, 2024
Q1 2024
|
Prelude Capital Management, LLC
New York, NY |
BUY
|
- |
29.5KNew |
$16.2K - $31.9K
|
29.5K
$26K
|
|
|
May 02, 2024
Q1 2024
|
Fny Investment Advisers, LLC
|
BUY
|
- |
27.5KNew |
$15.1K - $29.7K
|
27.5K
$24.2K
|
|
|
Apr 23, 2024
Q1 2024
|
Summit Trail Advisors, LLC
New York, NY |
BUY
|
- |
16KNew |
$8.8K - $17.3K
|
16K
$14.1K
|
|
|
Nov 05, 2024
Q1 2024
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
167+ 45.63% |
$91.9 - $180
|
533
$469
|
|
|
May 15, 2024
Q1 2024
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
65+ 13.89% |
$35.8 - $70.2
|
533
$469
|
|
|
May 10, 2024
Q1 2024
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
2+ 1.89% |
$1.1 - $2.16
|
108
$95
|
|
|
Apr 30, 2024
Q1 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
May 10, 2024
Q1 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-113- 3.96% |
$62.2 - $122
|
2.74K
$2.41K
|
|
|
May 10, 2024
Q1 2024
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-1.51K- 3.22% |
$829 - $1.63K
|
45.4K
$39.9K
|
|
|
May 15, 2024
Q1 2024
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-2.82K- 20.19% |
$1.55K - $3.05K
|
11.2K
$9.81K
|
|
|
May 15, 2024
Q1 2024
|
Bridgeway Capital Management, LLC
Houston, TX |
SELL
|
- |
-84.4K- 54.28% |
$46.4K - $91.2K
|
71.1K
$62.6K
|
|
|
Oct 17, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-891K- 80.06% |
$490K - $962K
|
222K
$195K
|
|
|
May 03, 2024
Q1 2024
|
Atlas Venture Life Science Advisors, LLC
|
SELL
|
- |
-1.77M- 64.02% |
$972K - $1.91M
|
993K
$874K
|